Procurement of medicines for 2026 Biological therapy

Deadline:N/A

Tender information
Extra-Regio level 3
North Makedonia
Type
Contract
Procedure
Unknown
Procurement of medicines for 2026 Biological therapy

L01FG01 Bevacizumab biosimilar 400 mg/16 ml

L01FG01 Bevacizumab biosimilar 400 mg/16 ml

L01EX27 Capivasertib 200mg

L01EX27 Capivasertib 200mg

Buyer
University clinic of radiotherapy and oncology
buyer-email@mail.com
organization number

Documents

Document name
Upload date
File size
First document.pdf
1 Jan 1970, 00:001 Bytes
Second document.pdf
1 Jan 1970, 00:001 Bytes
No time limit
Important dates
17 Jun - Publication date
Unlock Full Access with Mercell Bidding Business Plus
Start your free trial to explore exclusive features that help you win more tenders, faster:
AI-Powered Tender Insights
Buyer Contact Info
Key Tender Timelines

Already have an account?

Mercell Logo

Feel free to reach out!

Mercell is the leading European provider of e-tendering and procurement systems, and information between buyers and suppliers in the professional market.

We appreciate your input.

© Mercell Group 2026

Terms & Conditions and Privacy Notice

Mercell Group

  • Email: post@mercell.com
  • Phone: +47 21 01 88 00
  • Address: Askekroken 11, 0277 Oslo, Norway

Your privacy is important to us

We use cookies to improve your experience and evaluate each item on our site. By clicking further, you accept our use of cookies.